Phakellistatin 14

General Information


DRACP ID  DRACP02945

Peptide Name   Phakellistatin 14

Sequence  AIPFXAX

Sequence Length  7

UniProt ID  Not available

PubChem CID  11308763 

Origin  Phakellia sp

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
P388 Mouse lymphoma Lymphoma ED50=0.0042 μg/mL Not available Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  NCB: Ala1<--->X7

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X(5)=β-OMe-Asp; X(7)=Met(SO)

Chiral  L



Physicochemical Information


Formula  C26H35N5O4

Absent amino acids  CDEGHKLMNQRSTVWY

Common amino acids  AX

Mass  80880

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  4

Net charge  0

Boman Index  1152

Hydrophobicity  132.86

Aliphatic Index  84.29

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 15679318

Title  Isolation and structure of phakellistatin 14 from the Western Pacific marine sponge Phakellia sp

Doi 10.1021/np040092w

Year  2005

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.